APA

von Delft A., Humphreys I. S., Brown A., Pfafferott K., Lucas M., Klenerman P., Lauer G. M., Cox A. L., Gaudieri S. & Barnes E. (20160404). The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design. : Gut.

Chicago

von Delft Annette, Humphreys Isla S, Brown Anthony, Pfafferott Katja, Lucas Michaela, Klenerman Paul, Lauer Georg M, Cox Andrea L, Gaudieri Silvana and Barnes Eleanor. 20160404. The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design. : Gut.

Harvard

von Delft A., Humphreys I. S., Brown A., Pfafferott K., Lucas M., Klenerman P., Lauer G. M., Cox A. L., Gaudieri S. and Barnes E. (20160404). The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design. : Gut.

MLA

von Delft Annette, Humphreys Isla S, Brown Anthony, Pfafferott Katja, Lucas Michaela, Klenerman Paul, Lauer Georg M, Cox Andrea L, Gaudieri Silvana and Barnes Eleanor. The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design. : Gut. 20160404.